Precipio, Inc. — Board/Management Information 2009

May 21, 2009

8-K 1 v150555_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

May 21, 2009

TRANSGENOMIC, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-30975	911789357
(State
of Incorporation)	(Commission
File Number)	(IRS
Employer Identification
Number)

| 12325 Emmet Street, Omaha,

Nebraska	68164
(Address
of principal executive offices)	(Zip
Code)

(402) 452-5400

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | | --- | --- | | o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | | o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | | o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Item 5.02 Departure of Director.

Frank Witney, a member of the Board of Directors of Transgenomic, Inc., has submitted his resignation from the Board effective May 20, 2009. Mr. Witney’s resignation is due to his new role as President and Chief Executive Officer of Dionex.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Dated: May

21, 2009
By:	/s/ Debra A. Schneider Debra
A. Schneider Chief
Financial Officer